Updated January 23, 2021 Treatment with oral formulations of GS-441524 By Nicole Jacque, Niels C. Pedersen The initial field testing of GS-441524 for FIP treatment involved subcutaneous injection. This route of administration was based on prior pharmacokinetic (PK) studies done on laboratory cats. Intravenous and subcutaneous routes of injection yielded Read more…
This last year has been a milestone in our fight against FIP. We extended our landmark studies of 2018, when we published on a collaborative study with colleagues at Kansas State University on a drug called GC376. This was the first drug to successfully cure cats of FIP. In this Read more…
Dr. Pedersen has updated information about FIP in the “About FIP” category. Three additional articles entitled FIP Treatment, Black-Market Production and Sale of GS-441524 and GC376 and Neurological and ocular FIP have also been included in this same category. To the numerous owners of cats with FIP that contact us Read more…
September 9, 2019 Dear owner of a cat with FIP: I am receiving many emails and phone calls regarding cats that are either being treated with GS-441524 with or without help from veterinarians or from owners that intend to start treatment with GS from Chinese black-market sources and need advice. Read more…
Dr. Pedersen has updated the “FIP Treatment” article found in the “About FIP” category. There are two new articles posted in the “About FIP” category – one titled “Black-Market Production and Sale of GS-441524 and GC376” and the other titled “Neurological FIP”. To the numerous owners of cats with FIP that contact us daily: I am sorry but our Read more…
They are no longer accepting cats for treatment. The two drugs that have been researched both show great promise. They are now in various stages of being commercialized. It could take one or two years before any of these drugs are approved by the FDA and made available for use Read more…